J&J, Pfizer, Elan & Eli Lilly all aggressively see
Post# of 30028
Posted On: 09/03/2014 8:23:30 AM
J&J, Pfizer, Elan & Eli Lilly all aggressively seeking Alzheimer's Test
..........and all w/ failed past performances:
http://seekingalpha.com/article/1347691-amara...-diagnosis
..........and all w/ failed past performances:
http://seekingalpha.com/article/1347691-amara...-diagnosis
Quote:
"We point investors to the high profile failures of Pfizer / J&J's Bapineuzumab in 2012, or Eli Lilly's (LLY) Solanezumab in 2012, or Semagacestat in 2010. Elan's failures with Bapineuzumab have been well chronicled following the Phase II data in 2008."
"However Pfizer and new partner J&J, pushed forward in Phase III, thinking they had identified a sub-group of patients without a gene called ApoE4 though post hoc data mining. Some 4,100 patients, 4 years and $500-Mil. later, the Phase III trial still failed. Despite not learning much from their failure with Semagacestat in 2010, Eli Lilly's Solanezumab failed a Phase III study in Alzheimer's disease in 2012..."
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼